| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $17.3B | $16.5B | $14.8B | $13.6B | $13.0B | $12.0B | $11.5B | $9.5B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $10.3B | $4.7B | $-0.2B | $-1.3B | $1.6B | $5.6B | $4.8B | $2.3B |
| EPS (Basic) | $14.55 | $7.16 | $5.57 | $-1.17 | $2.77 | $8.54 | $5.32 | $-0.91 |
| EPS (Diluted) | $14.37 | $7.07 | $5.52 | $-1.17 | $2.73 | $8.45 | $5.23 | $-0.91 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $119.8B | $111.6B | $103.4B | $98.0B | $99.4B | $126.0B | $120.0B | $112.2B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.7B | $0.7B | $0.7B | $0.7B | $0.8B | $0.4B | $0.3B | $0.5B |
| Total Liabilities | $89.2B | $90.3B | $85.7B | $80.6B | $74.3B | $95.8B | $94.0B | $90.9B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $30.6B | $21.4B | $17.8B | $17.5B | $25.2B | $30.2B | $26.0B | $21.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $10.1B | $8.9B | $4.2B | $5.1B | $5.1B | $5.5B | $5.1B | $5.2B |
| Investing Cash Flow | $-7.3B | $-8.3B | $-3.0B | $-1.7B | $0.5B | $-3.4B | $-2.8B | $-1.7B |
| Capital Expenditures | $0.2B | $0.2B | $0.3B | $0.4B | $0.3B | $0.3B | $0.4B | $0.3B |
| Financing Cash Flow | $-2.9B | $-0.7B | $-1.2B | $-3.4B | $-5.2B | $-2.0B | $-2.5B | $-3.6B |